|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, December 12, 2018 ) Sleep apnea devices market is projected to reach USD 6.70 billion by 2021 from USD 4.59 billion in 2016, growing at a CAGR of 7.8% during forecast period. Growth of overall sleep apnea devices market can be attributed to growing awareness regarding ill effects of sleep apnea, growing usage of oral appliances for sleep apnea treatment, & large pool of undiagnosed and untreated sleep apnea patients.
Get Free Market Updates Now at https://www.reportsnreports.com/contacts/requestsample.aspx?name=802308 .
Emerging markets in developing countries and increasing venture capital (VC) funding are expected to provide immense opportunities for players in market.
Competitive Landscape
1 Overview
2 Market Share Analysis
3 Introduction
4 Sleep Apnea Devices Market Share Analysis, By Key Player (2015)
5 Resmed, Inc. (U.S.)
6 Philips Healthcare (Netherlands)
7 Fisher & Paykel Healthcare Ltd. (New Zealand)
8 Competitive Situation and Trends
9 Product Launches
10 Agreements and Contracts
11 Acquisitions
Factors such as growing awareness regarding ill effects of sleep apnea, growing usage of oral appliances for sleep apnea treatment, & large pool of undiagnosed and untreated sleep apnea patients are driving growth of market. Additionally, technological advancements in sleep apnea devices is also supporting growth of market. On other hand, lack of patient compliance and alternative treatments for sleep apnea are factors restricting market growth to a certain extent.
Get 15% Discount on Sleep Apnea Devices Market Now at https://www.reportsnreports.com/contacts/discount.aspx?name=802308 .
ResMed, Inc. (U.S.), Philips Healthcare (Netherlands), and Fisher & Paykel Healthcare Ltd. (New Zealand)dominated the global sleep apnea devices market. The other players include SomnoMed Ltd. (Australia), Compumedics Limited (Australia), Weinmann Medical Devices GmbH (Germany), Whole You, Inc. (U.S.), BMC Medical Co., Ltd. (China), DeVilbiss Healthcare (U.S.), and Braebon Medical Corporation (Canada).
The global market segmented on basis of product and end user. On basis of product, the market is categorized into therapeutic devices and diagnostic devices. In 2016, therapeutic devices segment is projected to command largest share of global sleep apnea devices market. This segment is also expected to grow at the highest growth rate in forecast period.
Place the Order Now at https://www.reportsnreports.com/purchase.aspx?name=802308 .
In-depth interviews were conducted with CEOs, sales and marketing directors, other innovation and technology directors, and executives from various key organizations operating in the sleep apnea devices market.
• By Company Type: Tier 1: 50%, Tier 2: 42%, Tier 3: 8%
• By Designation: Director Level: 58%, C-level: 25%, Others: 17%
• By Region: North America: 51.9%, Europe: 32.6%, APAC: 10.5%, RoW: 5.0%
On basis of diagnostic devices, PSG devices segment is estimated to account for largest share of market in 2016. These devices are used to study sleep patterns and physiological functions of a patient during sleep. Furthermore, single-channel screening devices segment is projected to register highest CAGR during forecast period. High growth of this segment can be attributed to its noninvasive and painless cardiorespiratory monitors that are used to assess oxygen saturation level of arterial blood.
ReportsnReports
Vishal
+ 18883915441
sales@reportsandreports.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
